Pharmacology of respiratory control in neonates and children.
The therapeutic approach of respiratory control disorders in neonates and young children is based on a clear understanding of the mechanisms involved in the regulation of ventilation according to the stages of postnatal development. A complete evaluation of drugs presenting either depressive or stimulative effects on ventilation is required.
Monin
P
P
Service de Médecine Infantile 1, Hôpital d'enfants, CHU, Nancy, France.
D000241:Adenosine / Q000502:physiology / Q000627:therapeutic use; D000818:Animals; D001049:Apnea / Q000188:drug therapy / Q000503:physiopathology; D002628:Chemoreceptor Cells / Q000502:physiology; D002648:Child; D002675:Child, Preschool; D004723:Endorphins / Q000502:physiology / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D011374:Progesterone / Q000627:therapeutic use; D012119:Respiration / Q000502:physiology*; D012120:Respiration Disorders / Q000188:drug therapy* / Q000503:physiopathology*; D005680:gamma-Aminobutyric Acid / Q000502:physiology / Q000627:therapeutic use
D004723:Endorphins; D011374:Progesterone; D005680:gamma-Aminobutyric Acid; D000241:Adenosine